Myocardial infarction, stroke and arterial stenosis: time to reassess a major misunderstanding

Luca Saba1, Peter Libby2

  • 1Department of Radiology, Azienda Ospedaliero-Universitaria di Cagliari, Polo di Monserrato, Cagliari, Italy.

PubMed

Insights

Arterial stenosis severity does not reliably predict acute ischemic events like heart attack or stroke. Current guidelines overemphasize stenosis grading, neglecting plaque biology and pharmacological treatments for risk mitigation.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research

Background:

  • A persistent misconception links arterial stenosis directly to acute ischemic events, including myocardial infarction and cerebral stroke.
  • Current clinical guidelines often codify an approach based on the premise that occlusive arterial stenosis generally provokes ischemic events.

Purpose of the Study:

  • To challenge the traditional reliance on stenosis grading for therapeutic decisions in cardiovascular disease.
  • To highlight mechanistic differences between chronic ischemia and acute thrombotic events.
  • To advocate for a shift towards modifying plaque biology over solely addressing stenosis.

Main Methods:

  • Review of current clinical guidelines and their reliance on stenosis grading.
  • Analysis of recent evidence, including a major clinical trial, on the correlation between stenosis severity and acute thrombotic complications.
  • Examination of mechanistic differences between flow-limiting stenoses and acute atherothrombotic events.

Main Results:

  • Evidence suggests a lack of strong correlation between stenosis severity and acute thrombotic complications of atherosclerosis.
  • A significant proportion of major adverse cardiovascular events occur in individuals without obstructive coronary artery disease.
  • Mechanistic differences exist between chronic/inducible ischemia and acute thrombotic events.

Conclusions:

  • Traditional reliance on stenosis grading as a biomarker for therapeutic decision-making is questioned.
  • A shift towards modifying plaque biology, rather than solely focusing on stenosis, is advocated.
  • Pharmacological treatment should be a fundamental factor in cardiovascular risk mitigation.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
53
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
34
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47